Sentences with phrase «mixed earnings report»

The company's shares fell $ 8.96 at Tuesday's open after a mixed earnings report, costing the Oracle of Omaha some $ 712.9 million.

The restaurant chain had a mixed earnings report, beating earnings per share estimates, but missing on revenue expectations.

Not exact matches

Kraft Heinz stock rose more than 3 percent in extended trading after reporting mixed earnings.

Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

As a big week of earnings winds down, Canada's corporate citizens reported a mix of hits and misses Thursday evening.

05/02/2017 The stock market put in another mixed session today, as traders digested the latest batch of corporate earnings reports and speculated about the Federal Reserve's next move.

Recently, reported U.S. earnings have been mixed, with some large companies surprising on the downside due to a combination of rising costs and weaker than expected sales, giving rise to concerns that the trend of total profits may be heading lower.

Gross margin of 61.9 percent came in ahead of the 59.7 percent the analyst expected due to a favorable mix of higher - margin datacenter segment sales, while a lower - than - expected tax rate also helped the company report an earnings beat.

Restaurants and retail landlords reported a mixed bag of first - quarter earnings results on Wednesday (May 2), beating analysts» expectations in some cases...

Stifel and JMP Securities on Wednesday issued a report on Omega Healthcare Investors Inc (NYSE: OHI) after the company reported fourth - quarter earnings that were mixed.

Nike Inc (NYSE: NKE)'s mixed fiscal second - quarter earnings report Thursday will have bulls and bears debating the company's prospects into 2018 and beyond.

Earnings reports from US companies for the first quarter were mixed.

The «tech - xodus» from Alphabet appears to be a result of the company reporting somewhat mixed second - quarter earnings results.

Ford and Chrysler both reported second - quarter earnings this morning and the results are somewhat mixed.

E Ink Holdings has come out with its earnings report for the month of November though the picture that has come out points towards mixed success.

It is no wonder the typical publishing - industry pundit's reaction to our initial Author Earnings reports has been a mix of dismissal, denial, and suspicion.

Apple has issued its latest earnings report for its Q4 2013 period ending September 28, and the results are still lucrative but slightly more mixed than usual.

As my colleague Russ Koesterich points out in a recent post, economic data was mixed over the first quarter, with sluggish economic growth, a soft jobs report and weak manufacturing reports leading to diminishing consensus around company earnings.

This mixing of reported and operating earnings, coupled with an arbitrary extension of a medium - term observation to a very - long - term historical period, leads to dubious conclusions.

Twitter reported earnings on the 29th and the results were mixed with revenue and EBITDA both beating estimates but monetization measures just met consensus forecasts.

Video game retail giant GameStop today reported earnings for the quarter ended October 31, revealing a mixed bag of ups and downs.